DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

2 API Suppliers, 2 Listed Suppliers

2 API Suppliers
2 Listed Suppliers

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

DIGITAL CONTENT

1 NEWS #PharmaBuzz

media
1 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 Annual Reports

globalSalesInformation
1 Annual Reports

MARKET PLACE

1 APIs

marketPlace
1 APIs

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

1DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Asp015k hydrobromide, Asp-015k hydrobromide, Peficitinib hydrobromide [usan], U55xhz5x6p, 1353219-05-2, 1h-pyrrolo(2,3-b)pyridine-5-carboxamide, 4-((anti-5-hydroxytricyclo(3.3.1.13,7)dec-2-yl)amino)-, hydrobromide (1:1)

Molecular Formula

C₁₈H₂₃BrN₄O₂

Molecular Weight

407.3 g/mol

InChI Key

ZUVPMAPXNYGJQC-OGTXJUTESA-N

FDA UNII

U55XHZ5X6P

1 2D Structure

Peficitinib Hydrobromide

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

4-[[(1S,3R)-5-hydroxy-2-adamantyl]amino]-1H-pyrrolo[2,3-b]pyridine-5-carboxamide;hydrobromide

2.1.2 InChI

InChI=1S/C18H22N4O2.BrH/c19-16(23)13-8-21-17-12(1-2-20-17)15(13)22-14-10-3-9-4-11(14)7-18(24,5-9)6-10;/h1-2,8-11,14,24H,3-7H2,(H2,19,23)(H2,20,21,22);1H/t9?,10-,11+,14?,18?;

2.1.3 InChI Key

ZUVPMAPXNYGJQC-OGTXJUTESA-N

2.1.4 Canonical SMILES

C1C2CC3CC(C2)(CC1C3NC4=C5C=CNC5=NC=C4C(=O)N)O.Br

2.1.5 Isomeric SMILES

C1[C@@H]2CC3(C[C@@H](C2NC4=C5C=CNC5=NC=C4C(=O)N)CC1C3)O.Br

2.2 Other Identifiers

2.2.1 UNII

U55XHZ5X6P

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. Asp015k Hydrobromide

2. Asp-015k Hydrobromide

3. Peficitinib Hydrobromide [usan]

4. U55xhz5x6p

5. 1353219-05-2

6. 1h-pyrrolo(2,3-b)pyridine-5-carboxamide, 4-((anti-5-hydroxytricyclo(3.3.1.13,7)dec-2-yl)amino)-, Hydrobromide (1:1)

7. Asp 015k Hydrobromide

8. Unii-u55xhz5x6p

9. Smyraf (tn)

10. Schembl9990237

11. Chembl3137329

12. Schembl14876111

13. Schembl14876113

14. Peficitinib Hydrobromide (jan/usan)

15. Peficitinib Hydrobromide [who-dd]

16. D10721

17. Q27290703

18. 1h-pyrrolo(2,3-b)pyridine-5-carboxamide, 4-((5-hydroxytricyclo(3.3.1.13,7)dec-2-yl)amino)-, Hydrobromide (1:1), Stereoisomer

19. 4-(((1r,2s,3s,5s,7s)-5-hydroxyadamantan-2-yl)amino)-1h-pyrrolo(2,3-b)pyridine-5-carboxamide Monohydrobromide

2.4 Create Date

2012-11-30

3 Chemical and Physical Properties

Molecular Formula	C₁₈H₂₃BrN₄O₂
Molecular Weight	407.3 g/mol
Hydrogen Bond Donor Count	5
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	3
Exact Mass	406.10044 g/mol
Monoisotopic Mass	406.10044 g/mol
Topological Polar Surface Area	104 Å²
Heavy Atom Count	25
Formal Charge	0
Complexity	525
Isotope Atom Count	0
Defined Atom Stereocenter Count	2
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2